Innovative new methods and discoveries in next generation DNA sequencing (NGS) and molecular biology have fundamentally redefined the opportunities and challenges in reading and editing DNA, but advances in writing DNA have been incremental by comparison. T o deliver on the promise of potent new biopharmaceuticals, synthetic biology critically relies on advances in DNA synthesis for easy, affordable and fast access to accurate nucleic acid sequences.
